logologo
QuantliQuantli

Faeth Therapeutics, Inc

FTH

NASDAQ

Biotechnology

$32.34

USD

+3.79 (+13.27%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $737.74M

Volume 364.9K

Price Target

$56.00$60.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $60.00 and a min estimate of $56.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$58.25

Implied Upside

+80.1%

Analyst Covering

4

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0.2500 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Patrick R. Trucchio

HC Wainwright & Co.

Buy

Reiterated

4 days ago

Plus
Plus
Plus

Sean McCutcheon

Raymond James

Buy

Initiated

2 weeks ago

Plus
Plus
Plus

Jay Olson

Oppenheimer

Buy

Initiated

2 weeks ago

Plus
Plus
Plus

Jack Allen

Baird

Buy

Initiated

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

ACHV

Achieve Life Sciences Inc

$7.59

+4.7%

AURA

Aura Biosciences Inc

$7.69

+0.5%

DSGN

Design Therapeutics Inc

$14.83

+3.1%

ANNX

Annexon Inc

$5.29

+0.6%

CADL

Candel Therapeutics Inc

$11.72

-0.7%

RIGL

Rigel Pharmaceuticals Inc

$42.58

+4.4%

OLMA

Olema Pharmaceuticals Inc

$10.63

+1.1%

IMMX

Immix Biopharma Inc

$10.97

+0.5%